Nanexa AB
556833-0285ActiveNanexa redefines injectables using proprietary nanoengineering drug delivery technology.
Oversikt
- 10–19
- Ansatte
- 5–10mill SEK
- Omsetning
- 2010
- Grunnlagt
Nøkkelbeslutningstakere
David Westberg
CEO
Göran Ando
Chairman of the Board
Jonas Fransson
Head of Pharmaceutical Development
Mårten Rooth
CTO
+3 flere kontakter i Funnelfeedr
Beskrivelse
Nanexa is a pharmaceutical development company specializing in advanced drug delivery systems. Their core innovation is the proprietary PharmaShell® technology, which utilizes Atomic Layer Deposition (ALD) precision. This technology is designed to transform drug administration by enabling long-actin...
Tagger
Nøkkelord
Bedriftsinformasjon
- Bransje
- Annan naturvetenskaplig och teknisk forskning och utveckling
- Juridisk form
- Aktiebolag
- MVA-nummer
- SE556833028501
Beslutningstakere
7 kontakter i FunnelfeedrDavid Westberg
CEO
Göran Ando
Chairman of the Board
Jonas Fransson
Head of Pharmaceutical Development
Mårten Rooth
CTO
Cecilia Danckwardt-Lillieström
Chief Financial Officer
Björn Svanström
current CFO (leaving)
Bengt Gustavsson
Medical Director
Lignende bedrifter
20 lignende bedrifter i Funnelfeedr
NACAMED AS
Developing silicon nanoparticles for controlled, enhanced drug delivery systems.
Iconovo AB
10–19 ansatteLeading partner developing patented dry powder inhaler drug delivery systems.
Double Bond Pharmaceutical AB
5–9 ansatteDeveloping advanced drug delivery systems for targeted cancer and pneumonia treatment.
AcroPharma AB (publ)
0 ansatteDeveloping innovative preventive therapeutics for major human diseases.
PILA PHARMA AB
1–4 ansatteClinical stage biotech developing an oral obesity and diabetes treatment.
Utforsk mer
Spørsmål om Nanexa AB
Vil du se Funnelfeedr i aksjon?
Book en gratis demo og oppdag hvordan Funnelfeedr hjelper deg med å finne og konvertere dine ideelle kunder.
Book en demo